Click here for Analysts' Upgrades, Downgrades.Editor's Note: Green and red arrows refer to intraday stock price movement. NEW YORK ( TheStreet) -- Alimera Sciences ( ALIM) price target cut at Citi to $12 from $15 after FDA did not approve lluvien NDA. Maintain Buy rating. Google ( GOOG) target increased at Kaufman to $690. Company should benefit from strong domestic online holiday sales. Rovi ( ROVI) estimates, target raised at Wedbush. Shares of ROVI now seen reaching $59, according to Wedbush Securities. Estimates also increased, to match the company's new guidance, following the SNIC acquisition. Time Warner Cable ( TWC) target boosted at Argus to $75. Company is leveraged to benefit from a recovery in the economy. Buy rating.
HOST // Robert Powell
Retirement Planning Event
More from Stocks
At GDC, Amazon Reveals its Playbook for Dominating Game Development
Anchored by AWS and Twitch, Amazon is pitching an all-in-one toolkit for game developers. Its main rival is Microsoft, which announced a similar offering last week.
Nvidia's GTC Conference: Demand for Computing Power Drives Innovation
Nvidia CEO Jensen Huang talks about the demand for computing power at the company's GTC Conference.
Apple's Heart Study Tied to Its Watch Shows Promise but Also Some Challenges
The hope is that the Apple Watch can successfully identify a condition known as atrial fibrillation.
It's Hard to Be Negative When the Market Is Trading This Way
The strength in bank stocks in front of the Fed meeting is an indication there isn't real concern about an inverted yield curve.